Global report - January 31, 2018
Amazon, Berkshire Hathaway & JPMorgan forms independent healthcare company
The three corporate giants has announced that they would partner to cut US healthcare costs for hundreds of thousands of their employees. The alliance is a sign of how frustrated American businesses are with the state of the nation’s health care system and the rapidly spiraling cost of medical treatment. Non-for-profit venture The new, not-for-profit venture […]
Global report - January 29, 2018
Sanofi acquires Ablynx for 3.9 billion EUR
Sanofi will acquire the Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), just a few days after the company turned down Novo Nordisk’s bid. The acquisition is Sanofi’s second major takeover deal this month following its acquisition of Bioverativ. “Since our founding in 2001, our team has been focused on unlocking the power of […]
Acquisition - January 10, 2018
Takeda intends to acquire TiGenix
Takeda Pharmaceutical has announced its intention to acquire TiGenix, a biopharma company developing novel stem cell therapies for serious medical conditions, and the total value of the deal is estimated to approximately 520 million euro. As a result Takeda has entered into an offer and support agreement with TiGenix which provides for a recommended potential […]
Biotech Business - January 3, 2018
Biosimilars may cut health spending by $54 billion over next decade shows new report
According to a new analysis from RAND Corp, introducing biosimilar versions of complex biologic drugs could cut healthcare spending in the US by $54 billion over the next decade. The savings estimate is about 20 percent larger than a similar analysis done by RAND researchers three years ago, representing both improved analysis methods and rapid […]
Careers article - December 14, 2017
Elias Zerhouni is Executive of the Year
Elias Zerhouni, President of Sanofi R&D, was recently awarded ‘Executive of the Year’ at the 13th Annual Scrip Awards in London. Dr. Zerhouni was recognized for displaying exemplary leadership in his field by a panel of senior healthcare experts from across the world. He was commended for his role in the transformation of Sanofi’s Research […]
Global report - September 4, 2017
Pfizer’s patent criticized
The pharma giant was recently granted a patent on their vaccine for pneumonia in India, which has been highly questioned by for example Medecins sans Frontiers (MSF). The patent approval means that other pharma companies are not allowed to manufacture cheaper versions of the vaccine and this is a major backlash in the fight for […]
